Organization
Charité, Berlin, Germany
4 abstracts
Abstract
“EVOLVING THE MANAGEMENT OF RA” PROGRAMME: EDUCATIONAL TOOLS TO SUPPORT DAILY PRACTICEOrg: LUMC, Leiden, Netherlands, Kantonsspital St. Gallen, St. Gallen, Switzerland, Medizinische Universität Wien, Vienna, Austria, University of Debrecen, Debrecen, Hungary, University of Oxford, Oxford, United Kingdom,
Abstract
ADDING ULTRASOUND TO THE TREAT-TO-TARGET STRATEGY SHOWS NO BENEFIT IN ACHIEVEMENT OF REMISSION: RESULTS FROM THE BIODAM COHORT Org: LUMC, Leiden, Netherlands, ARC, Amsterdam, Netherlands, Charité, Berlin, Germany, SVUH, Dublin, Ireland, McMaster University, Hamilton, ON, Canada,
Abstract
BELIMUMAB, A BLYS-SPECIFIC INHIBITOR, REDUCES DISEASE ACTIVITY AND SEVERE FLARES IN SEROPOSITIVE SLE PATIENTS: BLISS-76 STUDY Org: The Karolinska Institute, Stockholm, Sweden, Rheuma Zentrum Favoriten, Vienna, Austria, David Geffen School of Medicine, Cedars-Sinai–UCLA, West Hollywood, CA, United States, Inst of Rheumatology, Prague, Czech Republic, OMRF, Oklahoma City, OK,
Abstract
BIOLOGIC MONOTHERAPY: A TREATMENT OPTION FOR ELDERLY RA PATIENTS WITH MULTIMORBID CONDITIONS Org: DRFZ, Berlin, Scientific Board, Vogelsang-Gommern, Rheumatologist, Bautzen, Rheumatologist, Vogelsang-Gommern, Charité, Berlin, Germany,